[ad_1]
in Localities July 22, 2018 <img src =" http://www.wakionline.com/content/uploads/2018/07/21/6b21b18f66. jpg "alt ="
Recommendation for the Elimination of Counterfeit Products and Poor Quality Products by Drug Alert, Market Research and Tracing
Local Manufacturers Organization , biologics, exchange of information on counterfeit medicines and monitoring of side effects
The Conference of Drug Regulatory Authorities of the Eastern Mediterranean Region concluded its sessions Including strengthening the capacity of regulators to regulate local manufacturers, as well as the ability of regulators to regulate biological drugs, as well as the elimination of counterfeit and low quality products in the region through pharmacovigilance, market research and monitoring,
On the last day of the conference, the conference has been witnessing a series of sessions on the control of medical product safety, Dr. Huda Langer presented the state of vigilance. In the Eastern Mediterranean Region, science and activities related to the detection, evaluation, understanding and prevention of side effects of drugs related to all safety issues.
Studies have indicated that they are not limited to pre-market clinical studies. The number of patients and the duration of the study may not be sufficient in most cases to detect rare symptoms only at a low rate, and the short duration of studies may lead to a lack of knowledge of side effects that do not appear
After that, Dr. Mbad Younis of Iraq reviewed his country's experience with medical product safety, while Dr. Mohammed Al- Rumeimi, MD, of Iraq, then he presented the Sultanate's experience on monitoring the safety of traditional and complementary medicine, and Dr. Adham Ismail of the World Health Organization gave a lecture on the safety of medical devices and medical supplies. Dr. Sawsan Barro presented the experience of Syria in the organization of donations in the field of medicines and the safety and effectiveness of donated medicines in Syria.
Dr. François Lieri gave a lecture on the regulation of medical products during epidemics Dr. Adi Nusseirat presented the role of regulators and drug control in the field of antimicrobial resistance and emphasized that The antimicrobial efficacy resistance of the prevention threatened a series of ever increasing infections caused by bacteria, parasites, viruses and fungi. And it threatens the resistance of antimicrobials to public health in the world is a serious threat that requires action on all sectors of government and society.
Dr. Uday Nusseirat noted that the success of major operations and the chemical treatment of cancer is compromised. Healthcare provided to patients with contagious infections outweighs the cost of care provided to patients with non-resistant infections due to longer illness, additional tests and more expensive drugs.
2018-07-22
Recommending the elimination of counterfeit products and substandard products by means of a pharmaceutical alert, a market investigation and a a follow-up
] Organization of local manufacturing companies, biologics, exchange of information on counterfeit medicines and monitoring of side effects of drugs
The recent conference of drug regulatory authorities of the Mediterranean Region Eastern has concluded by a number of important recommendations, Regulate local manufacturers and strengthen the ability of regulators to regulate biologic drugs and eliminate counterfeit and low quality products in the region through pharmacovigilance, l & # 39; 39 market research and monitoring, exchange of information on counterfeit medicines and monitoring of seco effects ndaires.
On Closing Day, the conference was the occasion of a series of sessions on the control of the safety of medical products and presented the state of pharmacovigilance in the region of the Eastern Mediterranean in science and activities related to the detection of side effects.
and noted that studies have confirmed that not only information from pre-marketing clinical studies, although this is an effective way to ensure the effectiveness of the drug and its safety and to evaluate the proportion of risk compared to its benefit, but the number of patients and the duration of the study may not be sufficient in most cases to detect rare symptoms and a short duration of studies can lead to a misunderstanding of the side effects that appear only after a long period of use of the drug,
After that, Dr. Mbad Yunus of Iraq reviewed the His country's experience in medical product safety and presented the Sultanate's experience in monitoring the safety of traditional and complementary medicines, Dr. Adham Ismail of the World Health Organization in bag on the control of the safety of medical devices and medical supplies
Then another session was devoted to the discussion of cases of public emergency and the organization of literature.
Dr. François Lieri gave a lecture on the regulation of medical products during epidemics and epidemics, and Dr. Adi Nusseirat presented the role of regulators and control of drugs in the field of antimicrobial resistance, then noted that the effectiveness of the prevention of antimicrobial resistance threatens a range of infections that keeps increasing, caused by bacteria, parasites, viruses and fungi and the effectiveness of treatment, and threatens antimicrobial resistance public health in the world
Dr. Uday Nusseirat noted that the success of major surgical operations and cancer chemotherapy are threatened without the availability of effective antibiotics and that the cost of health care for infected patients better withstands the costs of patient care Who has been infected with non-resistant infections in ison of prolonged illness, additional tests and the use of more expensive drugs.At the end of the lecture, Dr. Suha Al-Lawati presented the experience of the Sultanate in streamlining the Use of medicine,
The conclusion of the Conference of Drug Regulatory Authorities of the Eastern Mediterranean Region (translated from the Al-Watan website)
We are in fact not responsible for its content.
[ad_2]
Source link
